BANGALORE, India, Feb. 9, 2012 /CNW/ - Jubilant Biosys Ltd., a
Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced
today that they have achieved an early stage milestone in one of their
collaborative programs with Chadds Ford, Pa., USA-based Endo
Pharmaceuticals that has nominated a candidate into full development.
The novel molecule, targeting cancer, is anticipated to go into
clinical trials by late 2012. Jubilant and Endo will continue the collaboration in the development
phase as well.
The multi-target collaboration that began three years ago focuses on
Best in Class differentiated therapies to address the unmet needs of
cancer patients worldwide. The collaboration has since delivered multiple milestones across the
discovery phase. Endo will pursue development and commercialization of the compound,
while Jubilant becomes eligible to receive development milestones.
"We are very pleased and elated with this successful outcome, which is a
result of the excellent collaboration between the scientists at Endo
and Jubilant," said Sri Mosur, CEO & President, Global Drug Discovery and Development, Jubilant. "Jubilant has pioneered from India, a business model based on shared risk that enables it to
demonstrate the differentiated and novel outcomes that Jubilant
scientists are able to deliver through accelerated and affordable
innovation to its many collaborators."
Sandeep Gupta, Endo Pharmaceuticals, Senior Vice President, Discovery & Early Development, said, "I congratulate the Jubilant and Endo teams on achieving this important
milestone. It was their outstanding collaborative work and ingenuity
that enabled nomination of a development candidate ahead of schedule in
less than two years since inception of this program. Initiation of this
development program further validates Endo's unique collaborative drug
discovery approach which aims to address unmet medical needs and improve patient outcomes."
Jubilant Biosys Ltd. is a Bengaluru based subsidiary of Jubilant Life Sciences Ltd,
headquartered in Noida, India. Jubilant Biosys, provides integrated
drug discovery and development solutions to the global pharmaceutical
industry. It is a pioneer in collaborative discovery research and
development and is engaged in multiple partnerships with global
pharmaceutical industry in therapeutic areas of Oncology, CNS and
SOURCE Jubilant Biosys Ltd
For further information:
Contact For Business Queries